openPR Logo
Press release

Ankylosing Spondylitis Global Market Report 2025: Strong Growth Fueled by Biosimilar Availability and Emphasis on Patient-Reported Outcomes

01-24-2025 12:29 PM CET | Health & Medicine

Press release from: The Business Research Company

Ankylosing Spondylitis Global Market Size Report 2025

Ankylosing Spondylitis Global Market Size Report 2025

Projected high growth rate and increased development of biologic treatments will propel the ankylosing spondylitis global market to new heights.

What Is The Projected Market Size Of The Global Ankylosing Spondylitis Global Market Report 2025 And Its Growth Rate?
•The ankylosing spondylitis market size has grown strongly in recent years. It is predicted to grow from $5.9 billion in 2024 to $6.36 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%.
•The market size is expected to see strong growth in the next few years, growing to $8.71 billion in 2029 at a CAGR of 8.2%.

What Is Driving The Growth In The Ankylosing Spondylitis Global Market Report 2025?
The increasing geriatric population is expected to propel the growth of the ankylosing spondylitis market going forward. Statistics indicate that the global population of individuals aged 65 and older is expected to more than double, increasing from 761 million in 2021 to 1.6 billion by 2050. This dramatic demographic shift has increased the number and proportion of people over the age of 60, stimulating the thrust for improved mobility and pain management in this population segment, particularly those suffering from ankylosing spondylitis.

Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11962&type=smp

Who Are the Key Players Driving Ankylosing Spondylitis Global Market Report 2025 Growth?
•Pfizer Inc.
•Johnson & Johnson Pvt. Ltd.
•Merck & Co. Inc.
•AbbVie Inc.
•Novartis AG
•Bristol-Myers Squibb
•Eli Lilly and Company
•Gilead Sciences Inc.
•Boehringer Ingelheim International GmbH
•Amgen Inc.
•Cedars-Sinai
•Viatris Inc.
•Astellas Pharma Inc.
•AstraZeneca plc
•UCB Inc.
•Cipla Inc.
•Zydus Lifesciences Limited
•Celltrion Inc.
•Hetero Labs Ltd.
•UCSF Health
•Janssen Biotech Inc.
•Reliance Life Sciences Pvt. Ltd.

What Are The Key Trends In The Ankylosing Spondylitis Global Market Report 2025?
•Biosimilar availability
•Targeted pain therapies
•Patient-reported outcomes (pros) emphasis
•Community support programs
•Regenerative medicine exploration

What Are The Segments Of The Global Ankylosing Spondylitis Global Market Report 2025?
1) By Treatment Type: Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Anti-Rheumatic Drugs (DMARDS), Biological Therapies, Steroids, Physical Therapies, Surgery
2) By Molecule: Biologics, Biosimilar, Small Molecules
3) By Route Of Administration: Parenteral, Oral, Other Routes
4) By Application: Juveniles, Adults
5) By End User: Hospitals, Clinics, Research Laboratories, Other End Users

Which Region Leads The Ankylosing Spondylitis Global Market Report 2025?
North America was the largest region in the ankylosing spondylitis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period, encompassing growth opportunities in nations such as China, India, and Japan. The ankylosing spondylitis market report covers these key regions, as well as insights on Western Europe, Eastern Europe, South America, the Middle East, and Africa.

Pre-book the Report for Swift Delivery
https://www.thebusinessresearchcompany.com/report/ankylosing-spondylitis-global-market-report

What Is Covered In The Ankylosing Spondylitis Global Market Report 2025 Global Market Report?

- Market Size Analysis: Analyze the Ankylosing Spondylitis Global Market Report 2025 size by key regions, countries, product types, and applications.

- Market Segmentation Analysis: Identify various subsegments within the Ankylosing Spondylitis Global Market Report 2025 for effective categorization.

- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.

- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.

- Market Contribution: Evaluate contributions of different segments to the overall Ankylosing Spondylitis Global Market Report 2025 growth.

- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.

- Industry Challenges: Analyze challenges and risks affecting the Ankylosing Spondylitis Global Market Report 2025.

- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Request Customization for This Report
https://www.thebusinessresearchcompany.com/Customise?id=11962&type=smp

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ankylosing Spondylitis Global Market Report 2025: Strong Growth Fueled by Biosimilar Availability and Emphasis on Patient-Reported Outcomes here

News-ID: 3832319 • Views:

More Releases from The Business Research Company

Comprehensive Cutaneous T-Cell Lymphoma Market Forecast 2025-2034: Growth Trends and Strategic Shifts
Comprehensive Cutaneous T-Cell Lymphoma Market Forecast 2025-2034: Growth Trends …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Cutaneous T-Cell Lymphoma Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The overall valuation of the cutaneous t-cell lymphoma sector has experienced a robust uptrend lately, projected to advance from $2.54 billion in the year 2024 to reach $2.72 billion by 2025, reflecting a compound
Global Dysautonomia (Autonomic Dysfunction) Market Projected to Grow at 11.4% CAGR, Reaching $4.49 Billion by 2029
Global Dysautonomia (Autonomic Dysfunction) Market Projected to Grow at 11.4% CA …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Dysautonomia (Autonomic Dysfunction) Industry Market Size Be by 2025? The global market for dysautonomia, also recognized as autonomic dysfunction, has experienced substantial expansion recently and is projected to increase from its 2024 valuation of $2.62 billion to $2.92 billion by 2025, reflecting a consistent compound annual
Rising Blood Disorders Drive Growth In The Market: Transformative Forces Shaping the Coagulation Factor Deficiency Market Landscape in 2025
Rising Blood Disorders Drive Growth In The Market: Transformative Forces Shaping …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Coagulation Factor Deficiency Industry Market Size Be by 2025? The market catering to coagulation factor deficiencies has experienced robust expansion lately, projected to ascend from its 2024 valuation of $4.58 billion to $4.93 billion in 2025, marking a compound annual growth rate of 7.7%. Factors driving
Emerging Trends to Drive Diabetes Diagnostics Market Growth at 7.5% CAGR Through 2029
Emerging Trends to Drive Diabetes Diagnostics Market Growth at 7.5% CAGR Through …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Diabetes Diagnostics Market Size Growth Forecast: What to Expect by 2025? The sector dedicated to diabetes diagnostic solutions has demonstrated robust expansion lately, projecting an increase from its 2024 valuation of $25.39 billion to $27.31 billion by 2025, reflecting a compound annual growth rate of 7.6% throughout this period;

All 5 Releases


More Releases for Ankylosing

Ankylosing Spondylitis Market Trends That Will Shape the Next Decade: Insights f …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Ankylosing Spondylitis Market Size By 2025? The valuation of the ankylosing spondylitis sector has experienced robust expansion over the past few years, projected to advance from a figure of $5.9 billion in the year 2024 up to $6.34 billion by 2025, reflecting a compound annual
Ankylosing Spondylitis Market Surges With The Growing Geriatric Population World …
The Ankylosing Spondylitis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Current Ankylosing Spondylitis Market Size and Its Estimated Growth Rate? The Ankylosing Spondylitis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034.
Ankylosing Spondylitis Uncovered: Market Dynamics and Future Projections
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.alliedmarketresearch.com/request-sample/2638 Introduction: The global ankylosing spondylitis market has been on a steady rise, reflecting the growing awareness and prevalence of this inflammatory condition. With a remarkable market size of $5,140.94 million in 2020, the projections indicate a substantial leap to $8,110.59 million by 2030. Ankylosing spondylitis, often misunderstood, is a complex disorder that affects the spine's flexibility and posture, potentially leading to severe complications if not managed effectively. Unveiling Ankylosing
Ankylosing Spondylitis Treatment Market to Witness Astonishing Growth by 2029
This Ankylosing Spondylitis Treatment Market research report focuses more on a number of distinctive as well as foremost market sectors. It further focuses market segmentation. Industry-specific interviews are carried out with market players to foresee future business growth. Various facets of the industry are also depicted here under each industry sector. Future development visions and a wide range of subjects are covered in this Ankylosing Spondylitis Treatment Market study report.
Ankylosing Spondylitis Market Overview With Detailed Analysis 2022-2028
According to Precision Business Insights (PBI), the latest report, ankylosing spondylitis market is expected to be valued at USD 5,460.5 million in 2022 which is expected to grow at a CAGR of 4.8% over 2022-2028. The primary factors that drive the market are the presence of biosimilars, usage of novel products, and increasing prevalence of ankylosing spondylitis. View the detailed report description here - https://precisionbusinessinsights.com/market-reports/ankylosing-spondylitis-market/ Retail Pharmacy to Dominate the
Ankylosing Spondylitis Market Challenges and Investment Opportunities by 2027
Allied Market Research published a report, titled, “Ankylosing Spondylitis Market: Global Opportunity Analysis and Industry Forecast 2020–2027.” According to the report, the global Ankylosing Spondylitis industry garnered $XX billion in 2019, and is expected to generate $xx billion by 2027, witnessing a CAGR of xx% from 2020 to 2027. Click Here To Access Sample Report https://www.alliedmarketresearch.com/request-sample/10631 Major players analyzed include AbbVie Inc., Janssen Pharmaceuticals Inc., Pfizer Inc., Sandoz International GmbH, Amgen